Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,007 | 90 | 96.6% |
| Education | $55.50 | 1 | 1.8% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $51.69 | 1 | 1.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Otsuka America Pharmaceutical, Inc. | $723.48 | 16 | $0 (2024) |
| Alkermes, Inc. | $310.70 | 14 | $0 (2023) |
| ITI, Inc. | $271.04 | 4 | $0 (2023) |
| Indivior Inc. | $212.67 | 5 | $0 (2021) |
| Braeburn Inc. | $201.90 | 8 | $0 (2024) |
| Allergan, Inc. | $200.92 | 9 | $0 (2022) |
| Orexo US, Inc. | $150.31 | 4 | $0 (2020) |
| Takeda Pharmaceuticals U.S.A., Inc. | $149.23 | 9 | $0 (2024) |
| Galderma Laboratories, L.P. | $148.47 | 7 | $0 (2024) |
| Novo Nordisk Inc | $133.82 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,319 | 30 | Otsuka America Pharmaceutical, Inc. ($568.34) |
| 2023 | $486.11 | 19 | Otsuka America Pharmaceutical, Inc. ($142.91) |
| 2022 | $336.43 | 9 | ITI, Inc. ($129.66) |
| 2021 | $67.86 | 5 | Takeda Pharmaceuticals U.S.A., Inc. ($30.00) |
| 2020 | $72.42 | 4 | Allergan, Inc. ($35.84) |
| 2019 | $211.68 | 9 | Alkermes, Inc. ($107.84) |
| 2018 | $490.17 | 13 | Indivior Inc. ($148.03) |
| 2017 | $130.94 | 3 | Galderma Laboratories, L.P. ($55.50) |
All Payment Transactions
92 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Braeburn Inc. | BRIXADI (Drug) | Food and Beverage | Cash or cash equivalent | $119.70 | General |
| Category: Opioid Use Disorder | ||||||
| 12/13/2024 | REVANCE THERAPEUTICS, INC. | DAXXIFY (Drug) | Food and Beverage | In-kind items and services | $122.69 | General |
| Category: AESTHETICS AND THERAPEUTICS | ||||||
| 11/27/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $13.60 | General |
| Category: PSYCHIATRY | ||||||
| 11/19/2024 | Otsuka America Pharmaceutical, Inc. | — | Food and Beverage | In-kind items and services | $121.98 | General |
| 11/15/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.04 | General |
| Category: NEUROSCIENCE | ||||||
| 10/31/2024 | Braeburn Inc. | BRIXADI (Drug) | Food and Beverage | In-kind items and services | $11.91 | General |
| Category: Opioid Use Disorder | ||||||
| 10/31/2024 | Braeburn Inc. | BRIXADI (Drug) | Food and Beverage | In-kind items and services | $1.71 | General |
| Category: Opioid Use Disorder | ||||||
| 10/17/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $5.29 | General |
| Category: PSYCHIATRY | ||||||
| 09/26/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $126.42 | General |
| Category: PSYCHIATRY | ||||||
| 09/26/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $13.60 | General |
| Category: NEUROSCIENCE | ||||||
| 08/27/2024 | Braeburn Inc. | BRIXADI (Drug) | Food and Beverage | In-kind items and services | $16.62 | General |
| Category: Opioid Use Disorder | ||||||
| 07/23/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY ASIMTUFII (Drug), ABILIFY MAINTENA | Food and Beverage | In-kind items and services | $18.40 | General |
| Category: PSYCHIATRY | ||||||
| 07/16/2024 | Braeburn Inc. | BRIXADI (Drug) | Food and Beverage | In-kind items and services | $10.91 | General |
| Category: Opioid Use Disorder | ||||||
| 07/11/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $16.13 | General |
| Category: PSYCHIATRY | ||||||
| 06/18/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $27.54 | General |
| Category: PSYCHIATRY | ||||||
| 06/18/2024 | Bausch Health US, LLC | APLENZIN (Drug) | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: Neurology | ||||||
| 05/23/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $13.50 | General |
| Category: NEUROSCIENCE | ||||||
| 05/16/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $120.00 | General |
| Category: Obesity | ||||||
| 05/15/2024 | Galderma Laboratories, L.P. | DYSPORT (Biological) | Food and Beverage | In-kind items and services | $13.55 | General |
| 05/14/2024 | Braeburn Inc. | BRIXADI (Drug) | Food and Beverage | In-kind items and services | $14.29 | General |
| Category: Opioid Use Disorder | ||||||
| 05/02/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $18.59 | General |
| Category: VIROLOGY | ||||||
| 04/24/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: PSYCHIATRY | ||||||
| 03/29/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $15.62 | General |
| Category: VIROLOGY | ||||||
| 03/26/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: PSYCHIATRY | ||||||
| 03/14/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $15.90 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 24 | 41 | $4,865 | $2,716 |
All Medicare Procedures & Services
2 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 11 | 19 | $3,179 | $1,937 | 60.9% |
| 99484 | Care management services for behavioral health conditions, 20 minutes or more clinical staff time directed by health care professional | Office | 2023 | 13 | 22 | $1,686 | $779.68 | 46.3% |
About Dr. Alberto Larrieu, MD
Dr. Alberto Larrieu, MD is a Family Medicine healthcare provider based in Feasterville Trevose, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/08/2006. The National Provider Identifier (NPI) number assigned to this provider is 1447209614.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Alberto Larrieu, MD has received a total of $3,114 in payments from pharmaceutical and medical device companies, with $1,319 received in 2024. These payments were reported across 92 transactions from 17 companies. The most common payment nature is "Food and Beverage" ($3,007).
As a Medicare-enrolled provider, Larrieu has provided services to 24 Medicare beneficiaries, totaling 41 services with total Medicare billing of $2,716. Data is available for 1 year (2023–2023), covering 2 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Feasterville Trevose, PA
- Active Since 05/08/2006
- Last Updated 04/08/2024
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1447209614
Products in Payments
- REXULTI (Drug) $443.48
- CAPLYTA (Drug) $396.04
- BRIXADI (Drug) $201.90
- SUBLOCADE (Drug) $160.98
- ABILIFY MAINTENA (Drug) $152.82
- Zubsolv (Drug) $150.31
- Vivitrol 380 mg (Drug) $140.24
- BOTOX COSMETIC (Biological) $135.63
- Wegovy (Drug) $133.82
- DAXXIFY (Drug) $122.69
- VIVITROL (Drug) $120.38
- TRINTELLIX (Drug) $119.23
- INJECTAFER (Drug) $113.40
- APLENZIN (Drug) $66.59
- XEOMIN (Biological) $65.95
- SUBOXONE SUBLINGUAL FILM (Drug) $51.69
- Vivitrol (Drug) $50.08
- MAVYRET (Drug) $34.21
- ABILIFY ASIMTUFII (Drug) $32.99
- BOTOX (Biological) $32.42
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Feasterville Trevose
John Mcdonald, D.o, D.O
Family Medicine — Payments: $9,701
Dr. Si Lam, Do, DO
Family Medicine — Payments: $4,395
Sean Duffy, Do, DO
Family Medicine — Payments: $2,905
Dr. Gilbert Kasirsky, D.o, D.O
Family Medicine — Payments: $2,513
Meredith Ray, Md, MD
Family Medicine — Payments: $1,540
Douglas Kimmel, D.o, D.O
Family Medicine — Payments: $1,058